FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117793740> ?p ?o ?g. }

• W2117793740 endingPage "e37" @default.
• W2117793740 startingPage "e37" @default.
• W2117793740 abstract "Despite treatment with agents that enhance beta-cell function and insulin action, reduction in beta-cell mass is relentless in patients with insulin resistance and type 2 diabetes mellitus. Insulin resistance is characterized by impaired signaling through the insulin/insulin receptor/insulin receptor substrate/PI-3K/Akt pathway, leading to elevation of negatively regulated substrates such as glycogen synthase kinase-3beta (Gsk-3beta). When elevated, this enzyme has antiproliferative and proapoptotic properties. In these studies, we designed experiments to determine the contribution of Gsk-3beta to regulation of beta-cell mass in two mouse models of insulin resistance. Mice lacking one allele of the insulin receptor (Ir+/-) exhibit insulin resistance and a doubling of beta-cell mass. Crossing these mice with those having haploinsufficiency for Gsk-3beta (Gsk-3beta+/-) reduced insulin resistance by augmenting whole-body glucose disposal, and significantly reduced beta-cell mass. In the second model, mice missing two alleles of the insulin receptor substrate 2 (Irs2-/-), like the Ir+/- mice, are insulin resistant, but develop profound beta-cell loss, resulting in early diabetes. We found that islets from these mice had a 4-fold elevation of Gsk-3beta activity associated with a marked reduction of beta-cell proliferation and increased apoptosis. Irs2-/- mice crossed with Gsk-3beta+/- mice preserved beta-cell mass by reversing the negative effects on proliferation and apoptosis, preventing onset of diabetes. Previous studies had shown that islets of Irs2-/- mice had increased cyclin-dependent kinase inhibitor p27(kip1) that was limiting for beta-cell replication, and reduced Pdx1 levels associated with increased cell death. Preservation of beta-cell mass in Gsk-3beta+/- Irs2-/- mice was accompanied by suppressed p27(kip1) levels and increased Pdx1 levels. To separate peripheral versus beta-cell-specific effects of reduction of Gsk3beta activity on preservation of beta-cell mass, mice homozygous for a floxed Gsk-3beta allele (Gsk-3(F/F)) were then crossed with rat insulin promoter-Cre (RIP-Cre) mice to produce beta-cell-specific knockout of Gsk-3beta (betaGsk-3beta-/-). Like Gsk-3beta+/- mice, betaGsk-3beta-/- mice also prevented the diabetes of the Irs2-/- mice. The results of these studies now define a new, negatively regulated substrate of the insulin signaling pathway specifically within beta-cells that when elevated, can impair replication and increase apoptosis, resulting in loss of beta-cells and diabetes. These results thus form the rationale for developing agents to inhibit this enzyme in obese insulin-resistant individuals to preserve beta-cells and prevent diabetes onset." @default.
• W2117793740 created "2016-06-24" @default.
• W2117793740 creator A5015348180 @default.
• W2117793740 creator A5023938814 @default.
• W2117793740 creator A5027447629 @default.
• W2117793740 creator A5033476856 @default.
• W2117793740 creator A5043927370 @default.
• W2117793740 creator A5052689605 @default.
• W2117793740 creator A5054486557 @default.
• W2117793740 creator A5056346771 @default.
• W2117793740 creator A5058965019 @default.
• W2117793740 creator A5074504026 @default.
• W2117793740 creator A5082403827 @default.
• W2117793740 creator A5083988476 @default.
• W2117793740 date "2008-02-19" @default.
• W2117793740 modified "2023-10-16" @default.
• W2117793740 title "Genetic Deficiency of Glycogen Synthase Kinase-3β Corrects Diabetes in Mouse Models of Insulin Resistance" @default.
• W2117793740 cites W1495740709 @default.
• W2117793740 cites W1503968406 @default.
• W2117793740 cites W1532532969 @default.
• W2117793740 cites W1556383867 @default.
• W2117793740 cites W1697523131 @default.
• W2117793740 cites W1794038664 @default.
• W2117793740 cites W1966611829 @default.
• W2117793740 cites W1987581156 @default.
• W2117793740 cites W2004269416 @default.
• W2117793740 cites W2005754586 @default.
• W2117793740 cites W2011747410 @default.
• W2117793740 cites W2014982455 @default.
• W2117793740 cites W2018926746 @default.
• W2117793740 cites W2019041110 @default.
• W2117793740 cites W2026542313 @default.
• W2117793740 cites W2040692229 @default.
• W2117793740 cites W2049875806 @default.
• W2117793740 cites W2053962169 @default.
• W2117793740 cites W2058138221 @default.
• W2117793740 cites W2064417575 @default.
• W2117793740 cites W2064438699 @default.
• W2117793740 cites W2064913654 @default.
• W2117793740 cites W2080778772 @default.
• W2117793740 cites W2080863734 @default.
• W2117793740 cites W2081359005 @default.
• W2117793740 cites W2083308747 @default.
• W2117793740 cites W2083547817 @default.
• W2117793740 cites W2090701958 @default.
• W2117793740 cites W2094836461 @default.
• W2117793740 cites W2098017074 @default.
• W2117793740 cites W2109479865 @default.
• W2117793740 cites W2113544353 @default.
• W2117793740 cites W2119584760 @default.
• W2117793740 cites W2130102556 @default.
• W2117793740 cites W2130143704 @default.
• W2117793740 cites W2130407178 @default.
• W2117793740 cites W2132557269 @default.
• W2117793740 cites W2133627256 @default.
• W2117793740 cites W2134199670 @default.
• W2117793740 cites W2136585808 @default.
• W2117793740 cites W2139997006 @default.
• W2117793740 cites W2142769261 @default.
• W2117793740 cites W2144792258 @default.
• W2117793740 cites W2146921827 @default.
• W2117793740 cites W2147777351 @default.
• W2117793740 cites W2151058113 @default.
• W2117793740 cites W2153169798 @default.
• W2117793740 cites W2153977812 @default.
• W2117793740 cites W2161399257 @default.
• W2117793740 cites W2167220221 @default.
• W2117793740 cites W2170537843 @default.
• W2117793740 cites W2261169782 @default.
• W2117793740 cites W56426715 @default.
• W2117793740 doi "https://doi.org/10.1371/journal.pbio.0060037" @default.
• W2117793740 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2245985" @default.
• W2117793740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18288891" @default.
• W2117793740 hasPublicationYear "2008" @default.
• W2117793740 type Work @default.
• W2117793740 sameAs 2117793740 @default.
• W2117793740 citedByCount "97" @default.
• W2117793740 countsByYear W21177937402012 @default.
• W2117793740 countsByYear W21177937402013 @default.
• W2117793740 countsByYear W21177937402014 @default.
• W2117793740 countsByYear W21177937402015 @default.
• W2117793740 countsByYear W21177937402016 @default.
• W2117793740 countsByYear W21177937402017 @default.
• W2117793740 countsByYear W21177937402018 @default.
• W2117793740 countsByYear W21177937402019 @default.
• W2117793740 countsByYear W21177937402020 @default.
• W2117793740 countsByYear W21177937402021 @default.
• W2117793740 countsByYear W21177937402022 @default.
• W2117793740 countsByYear W21177937402023 @default.
• W2117793740 crossrefType "journal-article" @default.
• W2117793740 hasAuthorship W2117793740A5015348180 @default.
• W2117793740 hasAuthorship W2117793740A5023938814 @default.
• W2117793740 hasAuthorship W2117793740A5027447629 @default.
• W2117793740 hasAuthorship W2117793740A5033476856 @default.
• W2117793740 hasAuthorship W2117793740A5043927370 @default.
• W2117793740 hasAuthorship W2117793740A5052689605 @default.
• W2117793740 hasAuthorship W2117793740A5054486557 @default.
• W2117793740 hasAuthorship W2117793740A5056346771 @default.

• next